RS-Thetaθ-field
The molecular key to the theta field. A first-principles model of endogenous DMT,
consciousness state transitions, and neuroprotection — machine-verified in Lean 4.
17 modules. Zero sorry.
git clone https://github.com/jonwashburn/recognition-science
python -m rstheta.cli analyze-eeg
python -m rstheta.cli ladder
python -m rstheta.cli neuroprotectionSource on GitHub · Paper (PDF) · MIT License
What Is This?
Your brain makes DMT. Not in tiny, accidental amounts — in concentrations comparable to serotonin. It makes it everywhere, not just in the pineal gland. And when your heart stops, your brain makes more of it.
The standard pharmacological model calls DMT a “hallucinogen” — a generator of false perceptions. Recognition Science says the opposite. DMT is the body’s endogenous molecular key to the theta field (Θ), the universal consciousness phase field derived from the same functional equation that gives you φ, the 8-tick cycle, and every particle mass.
This toolkit lets you explore the math behind that claim. Every formula traces to
one of 17 Lean 4 modules with zero sorry. The biology is a
model (consistent, testable); the physics is forced
(mathematically inevitable).
The Tether Mechanism
How can a living human access the theta field without dying? Through a tethered excursion. Your Z-pattern (the conserved integer that IS your consciousness) splits: part stays in the body, part couples to the theta field. A tether connects them. The body stays alive. You explore. You come back.
DMT amplifies the tether. The Sigma-1 receptor (Sig-1R) at the
ER–mitochondria interface is the cellular boundary modulator.
When DMT binds Sig-1R, the J-cost barrier drops:
barrier = baseline × (1 − activation).
At full activation, the barrier vanishes — but the tether remains,
because the Z-pattern is conserved.
This is why DMT is neuroprotective during cardiac arrest. It’s not a side effect. It’s the same mechanism — maintaining the tether while the body is under maximal stress.
Falsifiable Predictions
P1 EEG Phi-Resonance
DMT will preferentially amplify EEG power at 5φ ≈ 8.09 Hz, the carrier frequency of the theta field. Testable with existing psychedelic trial EEG data.
P2 Faraday Cage Attenuation
Inter-subject theta coherence during shared meditation or DMT sessions will be attenuated by electromagnetic shielding, since the tether operates at Ecoh = φ−5 eV.
P3 Discrete Analog Spacing
Tryptamine analogs (4-HO-DMT, 5-MeO-DMT, etc.) produce coupling/control ratios at discrete φ-ladder half-rungs, not a smooth continuum. The excursion depth is predicted by molecular weight.
P4 Pinealectomy Invariance
Pinealectomy does NOT prevent endogenous DMT release, because synthesis is distributed (cortex, choroid plexus, other neurons). Already confirmed (Borjigin et al., 2019).
Machine-Verified Proof Chain
Every claim traces back to the Recognition Composition Law through Lean 4 proofs.
Epistemic Boundary
FORCED (Lean-proved): J-cost uniqueness, φ-ladder geometry, 8-tick cycle, theta field existence, Z-pattern conservation.
MODEL (consistent, testable): DMT at the φ1 rung, Sig-1R as barrier modulator, NDE-to-theta injection, 5φ Hz carrier.
PREDICTION (falsifiable): 8.09 Hz EEG peak, Faraday attenuation, discrete analog spacing, pinealectomy invariance.
The Lean 4 proofs verify that the biological model is strictly consistent with the forced physics. They do not prove the biology is inevitable.